John A. Ward

Array ( [id] => 5850554 [patent_doc_number] => 20060233745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Enclosures housing cell-coated supports for treating tumors' [patent_app_type] => utility [patent_app_number] => 11/301138 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24504 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233745.pdf [firstpage_image] =>[orig_patent_app_number] => 11301138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5690120 [patent_doc_number] => 20060288435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'CD9/CD81 double-deficient non-human animal' [patent_app_type] => utility [patent_app_number] => 11/293388 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8548 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20060288435.pdf [firstpage_image] =>[orig_patent_app_number] => 11293388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11611016 [patent_doc_number] => 09648857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-16 [patent_title] => 'Methods of studying tolerance in MHC-II transgenic animals' [patent_app_type] => utility [patent_app_number] => 11/719876 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6338 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11719876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446429 [patent_doc_number] => 20090047655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Method Of Screening Candidate Drug' [patent_app_type] => utility [patent_app_number] => 11/667855 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5679 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047655.pdf [firstpage_image] =>[orig_patent_app_number] => 11667855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5273900 [patent_doc_number] => 20090077676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'PREMATURELY AGEING MOUSE MODELS FOR THE ROLE OF DNA DAMAGE IN AGEING AND INTERVENTION IN AGEING-RELATED PATHOLOGY' [patent_app_type] => utility [patent_app_number] => 11/719391 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 37839 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20090077676.pdf [firstpage_image] =>[orig_patent_app_number] => 11719391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828833 [patent_doc_number] => 20060063697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses' [patent_app_type] => utility [patent_app_number] => 11/269112 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26865 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063697.pdf [firstpage_image] =>[orig_patent_app_number] => 11269112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13981 [patent_doc_number] => 07807798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Human monoclonal antibodies to epidermal growth factor receptor' [patent_app_type] => utility [patent_app_number] => 11/267860 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 94 [patent_no_of_words] => 37687 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807798.pdf [firstpage_image] =>[orig_patent_app_number] => 11267860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4742161 [patent_doc_number] => 20080235814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom' [patent_app_type] => utility [patent_app_number] => 11/250805 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 20107 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20080235814.pdf [firstpage_image] =>[orig_patent_app_number] => 11250805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619020 [patent_doc_number] => 07998736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Adoptive immunotherapy with enhanced T lymphocyte survival' [patent_app_type] => utility [patent_app_number] => 11/576621 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 21521 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998736.pdf [firstpage_image] =>[orig_patent_app_number] => 11576621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5687757 [patent_doc_number] => 20060286072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => ' Techniques and compositions for treating cardiovascular disease by in vivo gene delivery' [patent_app_type] => utility [patent_app_number] => 11/236221 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 33737 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286072.pdf [firstpage_image] =>[orig_patent_app_number] => 11236221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085017 [patent_doc_number] => 20070275068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Controlled Release Delivery System for Bio-Active Agents' [patent_app_type] => utility [patent_app_number] => 11/575014 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17987 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275068.pdf [firstpage_image] =>[orig_patent_app_number] => 11575014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 289202 [patent_doc_number] => 07547817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions' [patent_app_type] => utility [patent_app_number] => 11/223359 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 31125 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547817.pdf [firstpage_image] =>[orig_patent_app_number] => 11223359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5799268 [patent_doc_number] => 20060034812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect' [patent_app_type] => utility [patent_app_number] => 11/221515 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10034 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034812.pdf [firstpage_image] =>[orig_patent_app_number] => 11221515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5813038 [patent_doc_number] => 20060083716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Composition for delivering an agent to a target cell and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/213499 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16293 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20060083716.pdf [firstpage_image] =>[orig_patent_app_number] => 11213499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534052 [patent_doc_number] => 20090233840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Modified Dynorphin Expression in Animals and Identification of Compounds for Treatment of Obesity and Diabetes' [patent_app_type] => utility [patent_app_number] => 11/573681 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 23363 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 50 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233840.pdf [firstpage_image] =>[orig_patent_app_number] => 11573681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699590 [patent_doc_number] => 20060216274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Induction of immune response to antigens expressed by recombinant adeno-associated virus' [patent_app_type] => utility [patent_app_number] => 11/199903 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21499 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216274.pdf [firstpage_image] =>[orig_patent_app_number] => 11199903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5799267 [patent_doc_number] => 20060034811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Melanoma vaccine and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 11/188849 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12632 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034811.pdf [firstpage_image] =>[orig_patent_app_number] => 11188849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894383 [patent_doc_number] => 20060002922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Method for preventing or treating obesity by modulating the activities of the pentose phosphate patway' [patent_app_type] => utility [patent_app_number] => 11/169944 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9442 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002922.pdf [firstpage_image] =>[orig_patent_app_number] => 11169944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5822382 [patent_doc_number] => 20060026695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Transgenically produced fusion proteins' [patent_app_type] => utility [patent_app_number] => 11/166994 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21246 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20060026695.pdf [firstpage_image] =>[orig_patent_app_number] => 11166994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336775 [patent_doc_number] => 20090053239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'ACACS As Modifiers of the IGF Pathway and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/628575 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16744 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053239.pdf [firstpage_image] =>[orig_patent_app_number] => 11628575 [rel_patent_id] =>[rel_patent_doc_number] =>)